Mid-large CRO with broad therapeutic capabilities and pragmatic trial delivery focus.
Vendor description
Best suited for sponsor teams that need delivery model flexibility within a scaled CRO.
Programs seeking balance between scale and execution focus.
- Operational execution
- Therapeutic know-how
- Publicly available evidence depth still maturing post-separation context
Approved customer reviews
Write a reviewBe the first customer to share verified experience with this vendor.
Review snapshot
Public employee feedback for Fortrea is mixed-positive overall. Reviews often mention good teams,flexibility,and reasonable work-life balance,but the negatives focus on career progression,uneven management,and stress following organizational change and separation from Labcorp. Employees seem to view it as a workable large-CRO environment,with experience varying noticeably by manager and function.
Team quality - flexibility - work-life balance - recognizable CRO platform
Career progression - uneven management - restructuring stress - inconsistent experience by team
Mixed-positive
Pricing
$
mid-market
Key facts
| HQ country | United States |
|---|---|
| Geography | Global |
| Service model | Full-service / FSP |
| Customer segment | mixed |
| Study phases | Phase I, Phase II, Phase III, Phase IV |
| Trial scale | Large global programmes and hybrid delivery models |
| Therapeutic areas | Generalist |
| Last reviewed | 2026-03-28 |
Related vendors
Editorial ranking
See how Fortrea compares - best Full-service CRO vendors for clinical trials.




